Enveric Biosciences, Inc. cotiza a 1.47 USD y tiene una capitalización bursátil de $7M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental healt…
| Periodo | 2025-03 | 2024-11 | 2024-08 | 2024-05 |
|---|---|---|---|---|
| Real | $-2.03 | $-43.20 | $-45.00 | $-109.80 |
| Estimado | $-2.76 | $-93.60 | $-99.00 | $-139.50 |
| Sorpresa | +26.4% | +53.8% | +54.5% | +21.3% |
| Métrica | ENVB | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -210.0% | -40.4% | -169.6% |
| ROA | -172.1% | -32.0% | -140.1% |
| Current Ratio | 5.38 | 2.84 | +2.54 |
| Debt / Equity | — | 0.28 | — |